169 related articles for article (PubMed ID: 2227135)
1. Induction of insulin resistance in vivo by amylin and calcitonin gene-related peptide.
Molina JM; Cooper GJ; Leighton B; Olefsky JM
Diabetes; 1990 Feb; 39(2):260-5. PubMed ID: 2227135
[TBL] [Abstract][Full Text] [Related]
2. The physiology of calcitonin gene-related peptide in the islet compared with that of islet amyloid polypeptide (amylin).
Bretherton-Watt D; Ghatei MA; Jamal H; Gilbey SG; Jones PM; Bloom SR
Ann N Y Acad Sci; 1992 Jun; 657():299-312. PubMed ID: 1637089
[TBL] [Abstract][Full Text] [Related]
3. Amylin found in amyloid deposits in human type 2 diabetes mellitus may be a hormone that regulates glycogen metabolism in skeletal muscle.
Cooper GJ; Leighton B; Dimitriadis GD; Parry-Billings M; Kowalchuk JM; Howland K; Rothbard JB; Willis AC; Reid KB
Proc Natl Acad Sci U S A; 1988 Oct; 85(20):7763-6. PubMed ID: 3051005
[TBL] [Abstract][Full Text] [Related]
4. Amylin and CGRP induce insulin resistance via a receptor distinct from cAMP-coupled CGRP receptor.
Kreutter DK; Orena SJ; Torchia AJ; Contillo LG; Andrews GC; Stevenson RW
Am J Physiol; 1993 Apr; 264(4 Pt 1):E606-13. PubMed ID: 8386456
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic amylin and calcitonin gene-related peptide cause resistance to insulin in skeletal muscle in vitro.
Leighton B; Cooper GJ
Nature; 1988 Oct; 335(6191):632-5. PubMed ID: 3050530
[TBL] [Abstract][Full Text] [Related]
6. Amylin-induced in vivo insulin resistance in conscious rats: the liver is more sensitive to amylin than peripheral tissues.
Koopmans SJ; van Mansfeld AD; Jansz HS; Krans HM; Radder JK; Frölich M; de Boer SF; Kreutter DK; Andrews GC; Maassen JA
Diabetologia; 1991 Apr; 34(4):218-24. PubMed ID: 2065857
[TBL] [Abstract][Full Text] [Related]
7. Islet amyloid polypeptide (IAPP/amylin) causes insulin resistance in perfused rat hindlimb muscle.
Tabata H; Hirayama J; Sowa R; Furuta H; Negoro T; Sanke T; Nanjo K
Diabetes Res Clin Pract; 1992 Jan; 15(1):57-61. PubMed ID: 1541236
[TBL] [Abstract][Full Text] [Related]
8. In vivo insulin resistance induced by amylin primarily through inhibition of insulin-stimulated glycogen synthesis in skeletal muscle.
Frontoni S; Choi SB; Banduch D; Rossetti L
Diabetes; 1991 May; 40(5):568-73. PubMed ID: 2022302
[TBL] [Abstract][Full Text] [Related]
9. Mechanism by which calcitonin gene-related peptide antagonizes insulin action in vivo.
Choi SB; Frontoni S; Rossetti L
Am J Physiol; 1991 Feb; 260(2 Pt 1):E321-5. PubMed ID: 1996634
[TBL] [Abstract][Full Text] [Related]
10. Failure of islet amyloid polypeptide to inhibit basal and glucose-stimulated insulin secretion in model experiments in mice and rats.
Pettersson M; Ahrén B
Acta Physiol Scand; 1990 Mar; 138(3):389-94. PubMed ID: 2183542
[TBL] [Abstract][Full Text] [Related]
11. Role of amylin in insulin secretion and action in humans: antagonist studies across the spectrum of insulin sensitivity.
Mather KJ; Paradisi G; Leaming R; Hook G; Steinberg HO; Fineberg N; Hanley R; Baron AD
Diabetes Metab Res Rev; 2002; 18(2):118-26. PubMed ID: 11994903
[TBL] [Abstract][Full Text] [Related]
12. The effect of islet amyloid polypeptide (amylin) and calcitonin gene-related peptide on glucose removal in the anaesthetized rat and on insulin secretion from rat pancreatic islets in vitro.
Tedstone AE; Nezzer T; Hughes SJ; Clark A; Matthews DR
Biosci Rep; 1990 Aug; 10(4):339-45. PubMed ID: 2249001
[TBL] [Abstract][Full Text] [Related]
13. [Amylin as an additional possible pathogenic factor in NIDDM and the insulin resistance syndrome].
Hrnciar J
Vnitr Lek; 1996 Aug; 42(8):557-60. PubMed ID: 8967027
[TBL] [Abstract][Full Text] [Related]
14. Reversal of the inhibitory effects of calcitonin gene-related peptide (CGRP) and amylin on insulin secretion by the 8-37 fragment of human CGRP.
Silvestre RA; Salas M; Dégano P; Peiró E; Marco J
Biochem Pharmacol; 1993 Jun; 45(11):2343-7. PubMed ID: 8517876
[TBL] [Abstract][Full Text] [Related]
15. Anti-insulin effects of amylin and calcitonin-gene-related peptide on hepatic glycogen metabolism.
Gómez-Foix AM; Rodriguez-Gil JE; Guinovart JJ
Biochem J; 1991 Jun; 276 ( Pt 3)(Pt 3):607-10. PubMed ID: 1905922
[TBL] [Abstract][Full Text] [Related]
16. The effect of amylin and calcitonin gene-related peptide on insulin-stimulated glucose transport in the diaphragm.
Hothersall JS; Muirhead RP; Wimalawansa S
Biochem Biophys Res Commun; 1990 Jun; 169(2):451-4. PubMed ID: 2192706
[TBL] [Abstract][Full Text] [Related]
17. Amylin, amyloid and age-related disease.
Cooper GJ; Tse CA
Drugs Aging; 1996 Sep; 9(3):202-12. PubMed ID: 8877314
[TBL] [Abstract][Full Text] [Related]
18. Dose response characteristics for the hyperglycemic, hyperlactemic, hypotensive and hypocalcemic actions of amylin and calcitonin gene-related peptide-I (CGRP alpha) in the fasted, anaesthetized rat.
Young AA; Rink TJ; Wang MW
Life Sci; 1993; 52(21):1717-26. PubMed ID: 8502117
[TBL] [Abstract][Full Text] [Related]
19. Different pharmacological characteristics in L6 and C2C12 muscle cells and intact rat skeletal muscle for amylin, CGRP and calcitonin.
Pittner RA; Wolfe-Lopez D; Young AA; Beaumont K
Br J Pharmacol; 1996 Mar; 117(5):847-52. PubMed ID: 8851500
[TBL] [Abstract][Full Text] [Related]
20. Amylin and amylin-amide lack an acute effect on blood glucose and insulin.
Ghatei MA; Datta HK; Zaidi M; Bretherton-Watt D; Wimalawansa SJ; MacIntyre I; Bloom SR
J Endocrinol; 1990 Feb; 124(2):R9-11. PubMed ID: 2179452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
